RecruitingNot ApplicableNCT06624826

Visual Performance of an Extended Depth of Focus IOL in an Emmetropic or Monovision Modality

Difference in Visual Performance of a Refractive Extended Depth of Focus Intraocular Lens in an Emmetropic or Monovision Modality

Sponsor

Prim. Prof. Dr. Oliver Findl, MBA

Enrollment

60 participants

Start Date

Oct 1, 2024

Study Type

INTERVENTIONAL

Conditions

Cataract

Summary

Comparison of the visual performance of a refractive extended depth of focus intraocular lens in an emmetropic or monovision modality

Eligibility

Min Age: 21 YearsMax Age: 105 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Emmetropic modality and a medical device called Monovision modality for people with cataract. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 105 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEmmetropic modality

PureSee IOL, emmetropic modality

DEVICEMonovision modality

PureSee IOL, monovision modality

Locations(1)

Vienna Institute for Research in Ocular Surgery

Vienna, Austria, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06624826

Related Trials

Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye

NCT076349131 location

Clinical Study to Confirm the Safety and Performance of the Virtuoso Phaco-vitrectomy Device

NCT067991561 location